摘要:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a protein-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
摘要:
The invention relates to computer architecture technology in the computer field. More specifically, the invention relates to a novel driving method for driving computer program/instruction execution, and a computer processor architecture and computer processor using the method. As one of the features of the invention, even on condition that no interrupt process is involved, the processor of this type can execute multiple programs in parallel on a single processor of this type exactly at the same time. Herein, the single processor relates to a single processor comprised of an instruction control section, an operation control section, a program memory section, a data memory section, and a communicating section. As another feature of the invention, a program execution driver (PED) is provided for each of the programs, and the multiple PED can manage and control the execution of multiple programs in parallel on the above single processor at the same time, independently or cooperatively with each other. The invention is adapted for design various computer processors, such as single chip micyocos, DSP and computer CPU with various scales.
摘要:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
摘要:
Isoflavone fatty acid ester derivatives of formula (I) or (II), the preparation method thereof and the pharmaceutical compositions containing such compounds are disclosed. The uses of such compounds in preparation of medicaments for preventing or treating hyperlipidemia, obesity or type II diabetes are also disclosed.
摘要:
The present invention relates to a magnetic suspension bearing supported by magnetic force, which comprises one or more magnets fixed on a shaft directly or indirectly which can rotate with said shaft, and matching magnets provided in a certain space, wherein the magnetic polarity and magnitude of magnetic force of the matching magnets match with the magnetic polarity and magnitude of magnetic force of said one or more magnets to achieve the full suspension rotation of said shaft, and said magnets and/or matching magnets are permanent magnets. The present invention is of simple design and large power, with many other advantages such as great rigidity and great load-bearing capability and widely use in various fields.
摘要:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
摘要:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
摘要:
The invention relates to an automation technology. The invention solves existing problems of insufficient flexibility, convenience and low security in purchasing corporate bills, and provides a corporate bill selling system with anti-counterfeiting verification, the technical solution thereof can be summarized as follows: a corporate bill selling system with anti-counterfeiting verification comprises a corporate bill selling center platform and at least one front-end corporate bill self-service terminal, the corporate bill selling center platform is connected with the at least one front-end corporate bill self-service terminal; the corporate bill selling center platform is used for providing entry of system basic platform building information, data storage, equipment monitoring, optical character recognition (OCR), interface with an external system and system data inquiry statistics management; and the front-end corporate bill self-service terminal is used for storing corporate bills, achieving interaction with users, and acquiring and identifying key information of corporate bills.
摘要:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
摘要:
Isoflavone fatty acid ester derivatives of formula (I) or (II), the preparation method thereof and the pharmaceutical compositions containing such compounds are disclosed. The uses of such compounds in preparation of medicaments for preventing or treating hyperlipidemia, obesity or type II diabetes are also disclosed.